Monaco Asset Management SAM Lowers Stake in Perrigo Company plc $PRGO

Monaco Asset Management SAM reduced its position in shares of Perrigo Company plc (NYSE:PRGO) by 42.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 100,000 shares of the company’s stock after selling 75,000 shares during the quarter. Monaco Asset Management SAM owned 0.07% of Perrigo worth $1,392,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. Impact Partnership Wealth LLC purchased a new stake in shares of Perrigo during the 4th quarter worth about $147,000. Norges Bank purchased a new stake in shares of Perrigo during the 4th quarter worth about $42,607,000. Savant Capital LLC purchased a new stake in shares of Perrigo during the 4th quarter worth about $143,000. Huntington National Bank boosted its stake in shares of Perrigo by 99.9% during the 4th quarter. Huntington National Bank now owns 4,741 shares of the company’s stock worth $66,000 after acquiring an additional 2,369 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in shares of Perrigo during the 4th quarter worth about $351,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on PRGO shares. Canaccord Genuity Group lowered their target price on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, February 27th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Jefferies Financial Group reaffirmed a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. Finally, Weiss Ratings lowered shares of Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $19.33.

Perrigo Trading Down 0.2%

Shares of Perrigo stock opened at $11.03 on Monday. The firm has a market capitalization of $1.53 billion, a PE ratio of -0.84, a P/E/G ratio of 1.30 and a beta of 0.51. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $28.43. The firm’s 50-day moving average price is $10.97 and its 200 day moving average price is $12.62. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.04. The firm had revenue of $841.80 million for the quarter, compared to analyst estimates of $1.04 billion. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. Perrigo’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period last year, the company posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, sell-side analysts predict that Perrigo Company plc will post 2.12 EPS for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th will be issued a $0.29 dividend. The ex-dividend date is Friday, May 29th. This represents a $1.16 dividend on an annualized basis and a yield of 10.5%. Perrigo’s dividend payout ratio is presently -8.85%.

Perrigo News Summary

Here are the key news stories impacting Perrigo this week:

• Positive Sentiment: Zacks Research raised its estimates for Perrigo’s Q3 2026, Q4 2026, Q2 2027, and Q4 2027 earnings, suggesting some expected improvement in later periods. Perrigo estimate updates
• Neutral Sentiment: The analyst kept a Hold rating on Perrigo, indicating no major change in overall stance despite the forecast revisions. Perrigo estimate updates
• Negative Sentiment: Zacks Research cut estimates for Q2 2026, Q1 2027, Q3 2027, FY2026, FY2027, FY2028, and Q1 2028, signaling a weaker near-term and medium-term earnings outlook. Perrigo estimate cuts
• Negative Sentiment: Perrigo’s most recent results showed revenue below expectations and sales down year over year, which can weigh on investor sentiment even though EPS came in ahead of estimates. Perrigo earnings results

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.